Mark Beveridge

Filings at 5 companies/Chief financial officer · Moberg Pharma AB (publ)

5 of 11 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 11. Reading the whole list, and the full company page behind every filing, is part of the subscription. So are this filer’s key figures — how many filings and open-market purchases they reported, and over which period — and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The 5 most recent of 11 visible filings, newest first.

Moberg Pharma AB (publ) Chief financial officer
104,617 SEKGrant
TradedJul 7, 2026FiledJul 7, 2026
Moberg Pharma AB (publ) Chief financial officer
321,583 SEKGrant
TradedJun 5, 2025FiledJun 10, 2025
Moberg Pharma AB (publ) Chief financial officer
382,626 SEKOpen-market sale
TradedJun 25, 2024FiledJun 26, 2024
Moberg Pharma AB (publ) Chief financial officer
674,099 SEKGrant
TradedJun 25, 2024FiledJun 26, 2024
Moberg Pharma AB Chief financial officer
17,730 SEKOpen-market buy
TradedNov 11, 2021FiledNov 11, 2021